Evidence map›Paper›PMID 30140999›Full record

ArticleClinical reviews in allergy & immunology2018

Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies.

Francesca Trentin, Mariele Gatto, Margherita Zen, Maddalena Larosa, Linda Nalotto, Francesca Saccon, Elisabetta Zanatta, Luca Iaccarino, Andrea Doria

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical reviews in allergy & immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Francesca TrentinDivision of Rheumatology, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy.
Mariele GattoDivision of Rheumatology, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy.
Margherita ZenDivision of Rheumatology, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy.
Maddalena LarosaDivision of Rheumatology, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy.
Linda NalottoDivision of Rheumatology, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy.
Francesca SacconDivision of Rheumatology, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy.
Elisabetta ZanattaDivision of Rheumatology, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy.
Luca IaccarinoDivision of Rheumatology, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy.
Andrea DoriaDivision of Rheumatology, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy. adoria@unipd.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The following changes are made for this article: (1.) Maddalena Larosa's given name and surname were inadvertently interchanged. The authorgroup section is now corrected. (2.) The author(s)' decision to opt for Open Choice.

Identifiers

PMID30140999
PMCPMC6182622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.